The Florida Breast Institute at Largo Medical Center has been granted a three-year/full accreditation designation by the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American College of Surgeons. Accreditation by the NAPBC is only given to those centers that have voluntarily committed to provide the highest level of quality breast care and that undergo a rigorous evaluation process and review of their performance.
During the survey process, the center must demonstrate compliance with standards established by the NAPBC for treating women who are diagnosed with the full spectrum of breast disease. The standards include proficiency in the areas of: center leadership, clinical management, research, community outreach, professional education, and quality improvement. A breast center that achieves NAPBC accreditation has demonstrated a firm commitment to offer its patients every significant advantage in their battle against breast disease.
“Since the Florida Breast Institute opened more than three years ago, our staff has provided that firm commitment to the breast healthcare needs of almost 15,000 patients,” said Richard Satcher, CEO of Largo Medical Center.
The NAPBC is a consortium of professional organizations dedicated to the improvement of the quality of care and monitoring of outcomes of patients with diseases of the breast. This mission is pursued through standard-setting, scientific validation, and patient and professional education.
“Largo Medical Center invites all women of Pinellas County to experience the difference our staff makes when it comes to personalized and individualized comprehensive services,” said Karen Kritsky, D.O., Medical Director of the Florida Breast Institute. “We provide some of the most remarkable services in our community taking a patient from her first visit, that may include an imaging study, to breast healthcare treatment and beyond.”
Receiving care at a NAPBC-accredited center ensures that a patient will have access to:
- comprehensive care, including a full range of state-of-the-art services
- a multidisciplinary team approach to coordinate the best treatment options
- information about ongoing clinical trials and new treatment options
- quality breast care close to home
The American Cancer Society (ACS) estimated that there would be 207,900 patients diagnosed with invasive breast cancer in the United States in 20101. In addition, hundreds of thousands of women who will deal with benign breast disease this year will require medical evaluation for treatment options.